Lela Buckingham to In Situ Hybridization, Fluorescence
This is a "connection" page, showing publications Lela Buckingham has written about In Situ Hybridization, Fluorescence.
Connection Strength
0.348
-
Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance. BMC Cancer. 2018 01 02; 18(1):2.
Score: 0.147
-
PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients. Int J Cancer. 2010 Apr 01; 126(7):1630-9.
Score: 0.086
-
The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib. J Thorac Oncol. 2007 May; 2(5):414-22.
Score: 0.070
-
Cryptic partial insertion of the RARA gene into the PML gene without reciprocal RARA-PML fusion: a case report and review of literature. Acta Oncol. 2020 Dec; 59(12):1496-1499.
Score: 0.044